surmount-1 tirzepatide weight loss percent nejm 2022 Presented at ECO 2025: In the SURMOUNT-5 phase 3b trial involving adults with obesity without type 2 diabetes, was superior to semaglutide in reducing body and waist circumference. Full trial Updates in Medicine | Phase

This broader selectivity profile fundamentally distinguishes Melanotan 2s pharmacology from PT-141s more targeted approach

Samuels, S.K

it's a little on the pricey side, but if yo Retatrutide side effectsmaybe

20 , e352 (2019)

Tirzepatide resulted in an early trend to reduction in eGFR at 12 weeks, but this was followed by an improvement in eGFR compared with placebo with longer duration treatment, and reduction in microalbuminuria

Ozempic 0.25 mg or 0.5 mg dose (2 mg/3 mL subcutaneous pen injector) NDC: 0169-4181-13 Days supply: Sample/initial (42 days) 1-month supply (28 days) Intent of prescription: Sample or initial prescription for new starts 1-month prescription for maintenance on 0.5 mg For patients with T2D and CKD, increase to the recommended maintenance dose of 1 mg after at least 4 weeks on 0.5 mg Strength: 2 mg per 3 mL (0.68 mg/mL) Dosage form: Solution SIG: Sample or initial Rx: Inject 0.25 mg SUBQ once weekly for 4 weeks, then 0.5 mg SUBQ once weekly for 2 weeks Maintenance Rx: Inject 0.5 mg SUBQ once weekly for 4 weeks Dispense quantity: 3 mL Dispense quantity unit of measure: mL ONLY Needles: 6 included Number of boxes: 1 box Ozempic 0.25 mg or 0.5 mg dose (2 mg/3 mL subcutaneous pen injector) NDC: 0169-4181-13 Days supply: 3-month supply (84 days) Intent of prescription: 3-month prescription for maintenance on 0.5 mg For patients with T2D and CKD, increase to the recommended maintenance dose of 1 mg after at least 4 weeks on 0.5 mg Strength: 2 mg per 3 mL (0.68 mg/mL) Dosage form: Solution SIG: Maintenance Rx: Inject 0.5 mg SUBQ once weekly for 12 weeks Dispense quantity: 9 mL Dispense quantity unit of measure: mL ONLY Needles: 18 included Number of boxes: 3 boxes Ozempic 1 mg dose (4 mg/3 mL subcutaneous pen injector) NDC: 0169-4130-13 Days supply: 1-month supply (28 days) Intent of prescription: 1-month prescription for maintenance on 1 mg Strength: 4 mg per 3 mL (1.34 mg/mL) Dosage form: Solution SIG: Maintenance Rx: Inject 1 mg SUBQ once weekly for 4 weeks Dispense quantity: 3 mL Dispense quantity unit of measure: mL ONLY Needles: 4 included Number of boxes: 1 box Ozempic 1 mg dose (4 mg/3 mL subcutaneous pen injector) NDC: 0169-4130-13 Days supply: 3-month supply (84 days) Intent of prescription: 3-month prescription for maintenance on 1 mg For patients with T2D and CKD, increase to the recommended maintenance dose of 1 mg Strength: 4 mg per 3 mL (1.34 mg/mL) Dosage form: Solution SIG: Maintenance Rx: Inject 1 mg SUBQ once weekly for 12 weeks Dispense quantity: 9 mL Dispense quantity unit of measure: mL ONLY Needles: 12 included Number of boxes: 3 boxes Ozempic 2 mg dose (8 mg/3 mL subcutaneous pen injector) NDC: 0169-4772-12 Days supply: 1-month supply (28 days) Intent of prescription: 1-month prescription for maintenance on 2 mg Strength: 8 mg per 3 mL (2.68 mg/mL) Dosage form: Solution SIG: Maintenance Rx: Inject 2 mg SUBQ once weekly for 4 weeks Dispense quantity: 3 mL Dispense quantity unit of measure: mL ONLY Needles: 4 included Number of boxes: 1 box Ozempic 2 mg dose (8 mg/3 mL subcutaneous pen injector) NDC: 0169-4772-12 Days supply: 3-month supply (84 days) Intent of prescription: 3-month prescription for maintenance on 2 mg Strength: 8 mg per 3 mL (2.68 mg/mL) Dosage form: Solution SIG: Maintenance Rx: Inject 2 mg SUBQ once weekly for 12 weeks Dispense quantity: 9 mL Dispense quantity unit of measure: mL ONLY Needles: 12 included Number of boxes: 3 boxes Saving Ozempic as a favorite in the EHR as a favorite in the EHR If your EHR allows you to save your frequently used prescriptions to a "favorites" list, be sure to add Ozempic pen for quicker access